Skip to content
Eight themes of vaccine hesitancy that could surprise people
According to a new study, vaccine hesitancy is a deeper issue than the ...
Read More
Summit on health care’s future shines light on PBM abuses
We need policy to improve patient access to drugs and address middlemen who ...
Read More
How cross-sector collaboration drives rare diseases cures
April is Sarocoidosis Awareness Month, an opportunity to raise awareness, promote understanding and ...
Read More
Lawmakers should help small biotechs gain capital, BIO Board Member tells House
Appropriate legislation can help innovative biotech firms working on the treatments of the ...
Read More
BIO survey: Tariffs threaten innovation, access to cures
U.S. tariffs on imports could increase the cost of biotechnology operations, threatening innovation ...
Read More
Autoimmune Awareness Month highlights diseases impacting 50M in U.S.
March is Autoimmune Awareness Month, and with an estimated 50 million people in ...
Read More
EDITORS' CHOICE
What BIO’s watching in the new Congress
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top priorities ...
Read More
LATEST NEWS
Health
Eight themes of vaccine hesitancy that could surprise people
According to a new study, vaccine hesitancy is a deeper issue than the prevalence of misinformation online. Rather, it reflects a deep mistrust in institutions ...
Federal Policy
Summit on health care’s future shines light on PBM abuses
We need policy to improve patient access to drugs and address middlemen who increase drug prices, according to participants in a March 27 healthcare conference ...
Latest News
How cross-sector collaboration drives rare diseases cures
April is Sarocoidosis Awareness Month, an opportunity to raise awareness, promote understanding and research, and create hope for the affected patients and their families. This ...
Federal Policy
Lawmakers should help small biotechs gain capital, BIO Board Member tells House
Appropriate legislation can help innovative biotech firms working on the treatments of the future to build capital, according to congressional testimony from Bill Newell, a ...
Agriculture
BIO survey: Tariffs threaten innovation, access to cures
U.S. tariffs on imports could increase the cost of biotechnology operations, threatening innovation that helps patients, according to a survey of biotech firms by the ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President ...
Read More
International
Bio's View
BIO celebrates release of FDA Rare Disease Innovation Hub 2025 strategic plan
February 28 is Rare Disease Day, and in observance, the Biotechnology Innovation Organization (BIO) is highlighting how it is working ...
Read More
